Cibus, Inc. (CBUS)
NasdaqCM · USD · Healthcare · Biotechnology
$1.37 (-1.79%) as of
Key statistics
- Market cap
- 104.71M
- Forward P/E
- -2.16
- EPS (TTM)
- -1.6200
- Dividend yield
- 0.00%
- 52-week range
- 1.0900 – 4.1910
- Beta
- 1.57
- Revenue (TTM)
- 4.35M
- Profit margin
- 0.00%
- Analyst target
- $14.33
- Volume
- 10.14k
About Cibus, Inc.
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- San Diego, CA, United States
- Employees
- 118
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.